Malorie Chabot-Blanchet

Colchicine for community-treated patients with COVID-19 (COLCORONA): a phase 3, randomised, double-blinded, adaptive, placebo-controlled, multicentre trial

Jean‐Claude Tardif, Nadia Bouabdallaoui, Philippe L. L’Allier et al. · The Lancet Respiratory Medicine · 2021 · 266 citations · Full text

Lipid lowering in healthy volunteers treated with multiple doses of MGL-3196, a liver-targeted thyroid hormone receptor-β agonist

Rebecca Taub, Edward Chiang, Malorie Chabot-Blanchet et al. · Atherosclerosis · 2013 · 153 citations

Molecular Pharmacology, Multiple Doses, Medicine +5

TNF-α Antagonist and Vascular Inflammation in Patients with Psoriasis Vulgaris: A Randomized Placebo-Controlled Study

Robert Bissonnette, François Harel, James G. Krueger et al. · Journal of Investigative Dermatology · 2017 · 93 citations

Inflammation, Autoimmune Disease, Vascular Inflammation +9

The Benefits Conferred by Radial Access for Cardiac Catheterization Are Offset by a Paradoxical Increase in the Rate of Vascular Access Site Complications With Femoral Access

Lorenzo Azzalini, Kunle Tosin, Malorie Chabot-Blanchet et al. · JACC: Cardiovascular Interventions · 2015 · 85 citations

Femoral Access, Device Therapy, Cardiovascular Disease +11

Brain-Derived Neurotrophic Factor Mitigates the Association Between Platelet Dysfunction and Cognitive Impairment

Jean-Christophe Bélanger, Véronique Bouchard, Jessica Le Blanc et al. · Frontiers in Cardiovascular Medicine · 2021 · 22 citations · Full text